Please ensure Javascript is enabled for purposes of website accessibility
Свяжитесь с нами Свяжитесь с нами
RU
Главная > Продукты > Наборы для анализа > Киты для Анализа ADA
Опции+
Опции
Подтвердить
  • Типы продуктов
    0 выбран
    Assay Kit (338)
  • Цель
    0 выбран
    Balstilimab (1)
    Olaratumab (1)
    Certolizumab (2)
    Tarextumab (1)
    Cabiralizumab (1)
    Tisotumab (1)
    Oleclumab (1)
    Vanucizumab (1)
    CD79B (2)
    Concizumab (1)
    Letolizumab (1)
    Bevacizumab (3)
    Dupilumab (3)
    Serclutamab (1)
    Clazakizumab (1)
    Ibritumomab (1)
    Conatumumab (1)
    Sotrovimab (1)
    Exenatide acetate (2)
    Guselkumab (3)
    Enfortumab (1)
    NP/Nucleocapsid (3)
    Mazdutide (1)
    Tibulizumab (1)
    Rafivirumab (1)
    dsDNA (1)
    Drozitumab (1)
    Alacizumab (1)
    Eldelumab (1)
    Cetrelimab (1)
    Sacituzumab (1)
    Tovetumab (1)
    Emactuzumab (1)
    Disitamab (1)
    Afasevikumab (1)
    Marstacimab (1)
    Rolinsatamab (1)
    Basiliximab (1)
    Amatuximab (1)
    Apamistamab (1)
    Brolucizumab (1)
    Astegolimab (1)
    Olokizumab (1)
    Mosunetuzumab (1)
    Mavezelimab (1)
    Dilpacimab (1)
    Casirivimab (1)
    Frovocimab (1)
    H3L (2)
    Nirsevimab (1)
    Etanercept (1)
    Vunakizumab (1)
    Glycoprotein (4)
    Favezelimab (1)
    Lexatumumab (1)
    Ramucirumab (1)
    Nivolumab (3)
    Bimagrumab (1)
    Golimumab (3)
    Urelumab (1)
    Imalumab (1)
    Zampilimab (1)
    Lupartumab (1)
    Ivuxolimab (1)
    Pertuzumab (3)
    Bimekizumab (1)
    Itolizumab (1)
    Camidanlumab (1)
    Anetumab (1)
    Ranibizumab (3)
    Iscalimab (1)
    Tesidolumab (1)
    Sirukumab (1)
    Ocaratuzumab (1)
    Semaglutide (1)
    Navicixizumab (1)
    Imdevimab (1)
    Lodelcizumab (1)
    E8L (4)
    Retatrutide (1)
    Palivizumab (3)
    Elotuzumab (1)
    Ianalumab (1)
    Tosatoxumab (1)
    Tigatuzumab (1)
    Lenzilumab (1)
    Pembrolizumab (3)
    Semorinemab (1)
    Ipilimumab (2)
    Utomilumab (1)
    Cixutumumab (1)
    Pogalizumab (1)
    Trastuzumab (2)
    Ixekizumab (1)
    Obinutuzumab (2)
    Anifrolumab (1)
    Daclizumab (1)
    Emibetuzumab (1)
    Varisacumab (1)
    Belantamab (1)
    Ziltivekimab (1)
    GP/Envelope glycoprotein (3)
    Omalizumab (2)
    A35R (4)
    β-D-Glucan (1)
    Suptavumab (1)
    Evolocumab (1)
    Romiplostim (1)
    Tiragolumab (2)
    Teclistamab (1)
    Carlumab (1)
    Indatuximab (1)
    Ascrinvacumab (1)
    Namilumab (1)
    Sintilimab (1)
    Tilavonemab (1)
    Tremelimumab (1)
    Daratumumab (3)
    Infliximab (2)
    Dalotuzumab (1)
    Andecaliximab (1)
    Vofatamab (1)
    Depatuxizumab (1)
    Tavolimab (1)
    Zanidatamab (1)
    Afutuzumab (1)
    Cusatuzumab (1)
    Ontamalimab (1)
    Varlilumab (1)
    Tanezumab (1)
    Obiltoxaximab (1)
    Tirzepatide (1)
    Atezolizumab (3)
    Denosumab (3)
    Tezepelumab (1)
    RBD (4)
    Alirocumab (1)
    Blosozumab (1)
    Eculizumab (3)
    Cergutuzumab (1)
    Otilimab (1)
    Tislelizumab (1)
    Zagotenemab (1)
    Zalifrelimab (1)
    Magrolimab (1)
    Figitumumab (1)
    Losatuxizumab (1)
    Lirilumab (1)
    Icrucumab (1)
    Vorsetuzumab (1)
    Ibalizumab (1)
    Tocilizumab (3)
    Crizanlizumab (1)
    Enoblituzumab (1)
    Avelumab (3)
    Cetuximab (3)
    RBD (Delta) (2)
    Siltuximab (3)
    Remtolumab (1)
    Suvizumab (1)
    Romosozumab (1)
    Inclacumab (1)
    Talacotuzumab (1)
    Adalimumab (3)
    Pasotuxizumab (1)
    Labetuzumab (1)
    Lorvotuzumab (1)
    Lintuzumab (1)
    Faricimab (1)
    Cinpanemab (1)
    Toripalimab (1)
    Ifabotuzumab (1)
    Canakinumab (1)
    Ganitumab (1)
    Farletuzumab (1)
    Oxelumab (1)
    Necitumumab (1)
    Zenocutuzumab (1)
    Epcoritamab (1)
    Tregalizumab (1)
    Glembatumumab (1)
    Natalizumab (2)
    Sarilumab (2)
    Mirzotamab (1)
    Gremubamab (1)
    Glycoprotein G (2)
    Durvalumab (3)
    A29L (4)
    Elezanumab (1)
    Spike glycoprotein (10)
    Secukinumab (2)
    Ustekinumab (3)
    Lacnotuzumab (1)
    Vibecotamab (1)
    Rosopatamab (2)
    Nesvacumab (1)
    Milatuzumab (1)
    Befovacimab (1)
    Edrecolomab (1)
    Gevokizumab (1)
    Sibrotuzumab (1)
    Teprotumumab (1)
    Mirvetuximab (1)
    Panitumumab (3)
    Codrituzumab (1)
    Glofitamab (1)
    Ieramilimab (1)
    Benufutamab (1)
    Meplazumab (1)
    Zanolimumab (1)
    Mirikizumab (2)
    Rituximab (1)
    Omburtamab (1)
    M1R (4)
    Pacmilimab (1)
    F/Fusion glycoprotein F0 (3)
    Spike Protein (Trimer) (2)
    CD20/MS4A1 (3)
    Foravirumab (1)
    RBD (Omicron/BA.5) (3)
  • Применения
    0 выбран
    ELISA (338)

Быстрый доступ

Свяжитесь с нами

  • +86-027-65523339

  • info@abinscience.com

  • Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China

  • linkedin
  • Ins
  • youtube
  • youtube
Авторские права © 2026 abinScience. Все права защищены. Все продукты предназначены только для исследовательского использования